Ling Yin

3.0k total citations · 1 hit paper
81 papers, 2.2k citations indexed

About

Ling Yin is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ling Yin has authored 81 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 23 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Ling Yin's work include DNA Repair Mechanisms (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer Cells and Metastasis (6 papers). Ling Yin is often cited by papers focused on DNA Repair Mechanisms (6 papers), Histone Deacetylase Inhibitors Research (6 papers) and Cancer Cells and Metastasis (6 papers). Ling Yin collaborates with scholars based in China, United States and Japan. Ling Yin's co-authors include Hui Qu, Xiong Cai, Rudi Bao, Hai-Xiao Zhai, Changgeng Qian, Cheng-Jung Lai, Zhaojun Liu, Omaida C. Velázquez, Jeffrey Forrester and Shan Zeng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

In The Last Decade

Ling Yin

78 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response

2022 167 citations Ling Yin et al. profile →

Peers

Ling Yin

ONCOL

PRM

Jan Hraběta Czechia

Michael Höpfner Germany

Jiajia Shen China

Ebbe Boedtkjer Denmark

Erika Di Zazzo Italy

Fuli Wang China

Hyunseung Lee South Korea

Patrizia Bottoni Italy

Anthony Tumber United Kingdom

Jan Hraběta Czechia

Ling Yin

1.6k ×1.2

606 ×1.1

ONCOL

273 ×0.6

193 ×0.8

117 ×0.5

PRM

Citations per year, relative to Ling Yin Ling Yin (= 1×) peers Jan Hraběta

Countries citing papers authored by Ling Yin

Since Specialization

Citations

This map shows the geographic impact of Ling Yin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Yin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Yin more than expected).

Fields of papers citing papers by Ling Yin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Yin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Yin. The network helps show where Ling Yin may publish in the future.

Co-authorship network of co-authors of Ling Yin

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Yin. A scholar is included among the top collaborators of Ling Yin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Yin. Ling Yin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yin, Ling, et al.. (2025). Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application. Journal of Medical Virology. 97(6). e70447–e70447. 2 indexed citations

Tang, Mengfan, Siting Li, Ziqiang Zhu, et al.. (2025). USP37 counteracts HLTF to protect damaged replication forks and promote survival of BRCA1-deficient cells and PARP inhibitor resistance. Nucleic Acids Research. 53(12).

Liu, Lianghong, et al.. (2025). Metal complexes against multidrug-resistant bacteria: recent advances (2020–present). Dalton Transactions. 54(46). 17025–17059. 1 indexed citations

Yin, Ling, et al.. (2024). Hu-Qi-Zheng-Xiao Decoction Inhibits the Metastasis of Hepatocellular Carcinoma Cells by Suppressing the HIF-1α Signaling Pathway to Inhibit EMT, LCSC, and Angiogenic Process. Integrative Cancer Therapies. 23. 1563541262–1563541262. 2 indexed citations

Deng, Li, et al.. (2023). Curcumin promotes skin wound healing by activating Nrf2 signaling pathways and inducing apoptosis in mice. TURKISH JOURNAL OF MEDICAL SCIENCES. 53(5). 1127–1135. 10 indexed citations

Zhang, Huimin, Yun Xiong, Yilun Sun, et al.. (2023). RAD54L2-mediated DNA damage avoidance pathway specifically preserves genome integrity in response to topoisomerase 2 poisons. Science Advances. 9(49). eadi6681–eadi6681. 9 indexed citations

Yao, Yichen, et al.. (2022). Primary tumor resection with or without metastasectomy for left- and right-sided stage IV colorectal cancer: an instrumental variable analysis. BMC Gastroenterology. 22(1). 114–114. 3 indexed citations

Jiao, Yang, Shu Wang, Xin Wang, et al.. (2022). The m6A reader YTHDC2 promotes SIRT3 expression by reducing the stabilization of KDM5B to improve mitochondrial metabolic reprogramming in diabetic peripheral neuropathy. Acta Diabetologica. 60(3). 387–399. 10 indexed citations

Yin, Ling, Yongji Zeng, Yuanhong Chen, et al.. (2021). Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer. Oncogene. 40(50). 6772–6785. 10 indexed citations

10.

Deng, Ganlu, Yihong Chen, Cao Guo, et al.. (2020). BMP4 promotes the metastasis of gastric cancer by inducing epithelial–mesenchymal transition via ID1. Journal of Cell Science. 133(11). 23 indexed citations

11.

Chen, Yihong, Ganlu Deng, Yaojie Fu, et al.. (2020). <p>FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK/ERK Signaling in Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 1625–1635. 40 indexed citations

12.

Yin, Ling, Geoffrey D. Keeler, Brad E. Hoffman, et al.. (2020). AAV3-miRNA vectors for growth suppression of human hepatocellular carcinoma cells in vitro and human liver tumors in a murine xenograft model in vivo. Gene Therapy. 28(7-8). 422–434. 24 indexed citations

13.

Wang, Rong, et al.. (2019). Expression profile analysis for epithelial-mesenchymal transition of breast cancer cell line DKTA based on microarray data. European Journal of Gynaecological Oncology. 40(4). 579–584. 1 indexed citations

14.

Shen, Hong, Ling Yin, Ganlu Deng, et al.. (2018). Knockdown of Beclin‐1 impairs epithelial‐mesenchymal transition of colon cancer cells. Journal of Cellular Biochemistry. 119(8). 7022–7031. 48 indexed citations

15.

Yin, Ling, et al.. (2018). Synthesis, biological evaluation and 3D-QSAR studies of 1,2,4-triazole-5-substituted carboxylic acid bioisosteres as uric acid transporter 1 (URAT1) inhibitors for the treatment of hyperuricemia associated with gout. Bioorganic & Medicinal Chemistry Letters. 29(3). 383–388. 29 indexed citations

16.

Ma, Junli, Shan Zeng, Yan Zhang, et al.. (2017). BMP4 promotes oxaliplatin resistance by an induction of epithelial-mesenchymal transition via MEK1/ERK/ELK1 signaling in hepatocellular carcinoma. Cancer Letters. 411. 117–129. 67 indexed citations

17.

Qian, Changgeng, Cheng-Jung Lai, Rudi Bao, et al.. (2012). Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling. Clinical Cancer Research. 18(15). 4104–4113. 188 indexed citations

18.

Lai, Cheng-Jung, Rudi Bao, Xu Tao, et al.. (2010). CUDC-101, a Multitargeted Inhibitor of Histone Deacetylase, Epidermal Growth Factor Receptor, and Human Epidermal Growth Factor Receptor 2, Exerts Potent Anticancer Activity. Cancer Research. 70(9). 3647–3656. 182 indexed citations

19.

Yin, Ling, et al.. (2010). A genetic screen for replication initiation defective (rid) mutants in Schizosaccharomyces pombe. Cell Division. 5(1). 20–20. 3 indexed citations

20.

Yin, Ling, et al.. (2008). Activation of the DNA Damage Checkpoint in Mutants Defective in DNA Replication Initiation. Molecular Biology of the Cell. 19(10). 4374–4382. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact